SCHEMBL7109285

SCHEMBL7109285

COc1[c]cccc1-c1ccsn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8205927 0.75 CYP2A6 (0.39)
SCHEMBL16720573 0.74 METAP2 (0.36)
SCHEMBL7453541 0.73 METAP2 (0.32)
SCHEMBL7446763 0.72 NPC1 (0.39)
SCHEMBL28872405 0.72 APP (0.50)
SCHEMBL10535184 0.72 APP (0.46)
SCHEMBL19127576 0.71 ERN1 (0.40)
SCHEMBL7447711 0.71 ALDH1A1 (0.38)
SCHEMBL7110942 0.71 PDPK1 (0.40)
SCHEMBL7453756 0.70 CLK4 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030008901-A1 Hydroxy pipecolate hydroxamic acid derivatives MCCLURE KIM F (US) 2003-01-09 US disclosed
US-20020019534-A1 Gem substituted hydroxamic acids PFIZER INC. 2002-02-14 US disclosed
CN-1316995-A Hydroxy 2-piperidinoate hydroxamic acid derivatives as MMP inhibitors PFIZER PROD INC (US) 2001-10-10 CN disclosed